Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "Oral feeding" patented technology

Computer Controlled Bottle for Oral Feeding of a Patient

Generally, the present invention relates to medical devices and more particularly to an computer controlled bottle system for example, for a preterm infant oral feeding. An embodiment of the invention is directed to a method for delivering nutritional fluids orally to a preterm infant comprising the steps of measuring the infant's inspired breath to breath amplitude, measuring the infant's intraoral sucking pressure, establishing threshold values for infant's inspired breath to breath amplitude and infant's intraoral sucking pressure, and delivering nutritional fluids to the infant only when the infant's inspired breath to breath amplitude and infant's intraoral sucking pressure both simultaneously satisfy their respective threshold values.
Owner:INFOSCITEX +2

Methods and devices for intramuscular stimulation of upper airway and swallowing muscle groups

Devices and methods were discovered that successfully provided patient autonomous control of both hyolaryngeal elevation, anterior hyoid motion and opening of the upper esophageal sphincter for swallowing by intramuscular stimulation of two muscles. The technology allows patient self stimulation of swallowing and can return oral feeding to dysphagia patients. Indwelling electrode stimulation of only two muscles generated as much as 80 % of normal synergistic movement leading to swallowing. The devices and methods also are useful for control of other upper respiratory muscle groups involved in speech and voice. Calibration techniques may be used in combination for greater freedom in setting and using electrodes over extended implantation time periods. These methods and devices can control complex movements of body solids such as bone and cartilage and tissues by electro stimulation of a minimum set of muscles simultaneously.
Owner:UNITED STATES OF AMERICA

Feeding device and feeding method for infants

A feeding device and a method for facilitating the transition from non-oral tube feeding to oral feeding is disclosed. The device comprises a fluid reservoir having a fluid outlet, a nipple having a fluid outlet, a shield attached to the nipple base, a conduit for conveying fluid from the reservoir to the nipple fluid outlet and a manually adjustable valve that is operable to prevent and control the flow of fluid through the conduit. The method comprises the steps of providing a device of the type just described, acclimating an infant to the device by closing the valve and inserting the nipple into the infant's mouth. The valve is then opened to permit the very slow flow of fluid through the nipple outlet. Additional feeding regimens are provided in which restriction of the flow of fluid is gradually relaxed over a series of feedings until the infant is able to withdraw about sixty cubic centimeters of fluid during a twenty minute feeding without distress.
Owner:RUTH ANTHONY M +1

Feeding device for infants

A feeding device especially for facilitating the transition from non-oral tube feeding to oral feeding is disclosed. The device comprises a fluid reservoir-having a fluid outlet, a nipple having a fluid outlet, a conduit for conveying fluid from the reservoir to the nipple fluid outlet and a manually adjustable valve that includes a manually settable selector to control the flow of fluid through the conduit and to vary it from zero flow to substantial flow. The device may include a shield associated with the nipple.
Owner:RUTH ANTHONY M +1

Methods and devices for intramuscular stimulation of upper airway and swallowing muscle groups

InactiveUS7606623B2ElectrotherapyChiropractic devicesImplantation timeUpper esophageal sphincter
Devices and methods were discovered that successfully provided patient autonomous control of both hyolaryngeal elevation, anterior hyoid motion and opening of the upper esophageal sphincter for swallowing by intramuscular stimulation of two muscles. The technology allows patient self stimulation of swallowing and can return oral feeding to dysphagia patients. Indwelling electrode stimulation of only two muscles generated as much as 80 % of normal synergistic movement leading to swallowing. The devices and methods also are useful for control of other upper respiratory muscle groups involved in speech and voice. Calibration techniques may be used in combination for greater freedom in setting and using electrodes over extended implantation time periods. These methods and devices can control complex movements of body solids such as bone and cartilage and tissues by electro stimulation of a minimum set of muscles simultaneously.
Owner:UNITED STATES OF AMERICA

Feeding device for infants

A feeding device especially for facilitating the transition from non-oral tube feeding to oral feeding is disclosed. The device comprises a fluid reservoir-having a fluid outlet, a nipple having a fluid outlet, a conduit for conveying fluid from the reservoir to the nipple fluid outlet and a manually adjustable valve that includes a manually settable selector to control the flow of fluid through the conduit and to vary it from zero flow to substantial flow. The device may include a shield associated with the nipple.
Owner:RUTH ANTHONY M +1

Automatic Pacing System for a Baby Bottle

ActiveUS20150335533A1Feeding-bottlesTeatsRefluxFull term infants
A baby bottle, an insert for a baby bottle, a baby bottle including an insert, and a method of feeding an infant that serves to pace the infant's feeding rhythm. Generally, these devices and methods will be of use for a preterm infant who lacks coordination of the suck-swallow-breathe synchrony, but can also be used with full term infants who can benefit from rigid control of the flow of milk from a bottle, this includes, but is not limited to, infants with gastroesophageal reflux who can require pacing of feeds to allow for gastric emptying. The device generally cues the infant to swallow and breathe after each 1-4 sucks by stopping the flow of the fluid from the bottle after the infant has sucked sufficiently or a predetermined period of time has passed. Once the baby breathes or a period of time passes, the bottle resets for the next repetition. The device also serves to consistently slow the flow of milk during oral feeding.
Owner:PREEMIE PACER

External medicine combination for treating skin allergic disease

Anaphylactic diseases comprising urticaria, papilla, subacute dermatitis, eczema, and the like, are skin diseases which seriously puzzle the human beings. In the invention, antihistamine, zinc salt and weak acid are prepared into a topical compound preparation, which not only reduces the untoward effect of drugs, avoids the first pass effect of the liver when feeding the drugs by mouth, avoids the blood concentration peak valley phenomenon caused by oral feeding, but also can improve the curative effect and is convenient for clinic application. Simultaneously pharmacological tests show that the topical compound preparation obtains excellent drug synergism to the anaphylactic skin diseases and has excellent effects on curing the anaphylactic diseases.
Owner:LUNAN PHARMA GROUP CORPORATION

Oral feeding bottle

An oral feeding bottle includes a feed container with an open end and surfaces adapted to come into contact with a liquid feed in the container, a teat releasably connected to the open end and adapted to contact both the liquid feed and a person or animal feeding from the bottle, and a cap with two modes of operation, where in the first mode, the teat is connected to the container and the cap is adapted to fit over, enclose the teat, and be releaseably connected to the feed container, and where in the second mode, the cap includes a means for stowing the teat in a non-dispensing position spaced from the container, where the teat and the surfaces that contact the liquid feed are in fluid communication so that the teat and the feed container are sterilized with a fluid sterilizing medium disposed in the container.
Owner:MRDC

Systems for monitoring infant oral motor kinetics during nutritive and non-nutritive feeding

The present invention relates to a system device and method for monitoring infant oral motor kinetics (OMK), which can be used to assess the functional significance of the different sucking components, i.e., the plasticity of infant sucking skills in relation to their oral feeding performance, at a particular time, during the developmental period and / or during preventive or therapeutic intervention programs. It is a unique system and apparatus that provides a means to study the nonnutritive and / or nutritive sucking skills, i.e., the Suction and / or Expression components of sucking, of infants in the natural setting, i.e., during a normal feeding session. OMK sensors, tracked in real-time by the monitoring system, include miniature pressure transducers, or pressure sensitive pads, attached to the nipple for measuring intraoral pressure pulses during Suction, and for measuring compression / stripping pressure pulses during Expression; and a miniature flow sensor for measuring fluid flow rate, which can be integrated over time to determine the volume of milk removed (bolus) per suck. Other signals, such as respiration, swallowing, thermal, optical, and acoustic signals can be recorded and compared along with the instrumented-nipple signals, in an OMK monitoring system.
Owner:LAU CHANTAL

Infant Oral Feeding System

InactiveUS20110266245A1Eliminate resistanceEliminate hydrostatic pressureDomestic plumbingFeeding-bottlesHydrostatic pressureWrist injury
An oral feeding system using anti-drip visual positioning markers and a unidirectional, anti-vacuum valve to simultaneously and rapidly eliminate the hydrostatic pressure and vacuum build-up, respectively, normally occurring in conventional feeding bottles. In one version, the anti-drip visual positioning markers and valve are part of the same bottle (standard or ergonomically-shaped). In another version, a nipple is held by a nipple crown that screws onto an adaptor with anti-drip visual positioning markers and a hole into which the anti-vacuum valve is inserted. The adaptor screws onto a standard or ergonomically designed feeding bottle. The anti-vacuum valve can have one or more extended tabs that make it easier to grip when removing the valve. The use of an ergonomically shaped, hard-wall bottle optimizes caregivers' comfort and minimize potential hand and / or wrist injury. Transparent materials can be used for the components of the system.
Owner:LAU CHANTAL

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

ActiveUS20160331816A1Improved right heart functionDecreased pulmonary vessel wall thicknessPowder deliveryPeptide/protein ingredientsDiseaseUveitis
Emerging evidence indicates that diminished activity of the vasoprotective axis of the renin-angiotensin system, constituting angiotensin converting enzyme2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to pulmonary hypertension (PH). However, clinical success for long-term delivery of ACE2 or Ang-(1-7) would require stability and ease of administration to increase patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect from acids and gastric enzymes; fusion to a transmucosal carrier facilitates effective systemic absorption. Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) attenuated monocrotaline (MCT)-induced increase in right ventricular systolic pressure, decreased pulmonary vessel wall thickness and improved right heart function in both prevention and reversal protocols. Furthermore, combination of ACE2 and Ang-(1-7) augmented the beneficial effects against cardio-pulmonary pathophysiology induced by MCT administration.Experiments have also been performed which indicate that this approach is also suitable for the treatment or inhibition of experimental uveitis and autoimmune uveoretinitis These studies provide proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary and ocular disease therapeutics.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA +1

Natural animal feed additive

The invention discloses a natural animal feed additive which comprises the following components in mass percentage: 10-25% of allicin, 1-5% of beta-glucanase, 20-40% of diatomaceous earth, 5-15% of potassium sorbate, 25-50% of beer yeast cell wall and 0.5-1% of vitamin C. Mixing materials which are 0.01-5% of the dry weight of the natural animal feed additive is added in the natural animal feed additive; and by carrying out oral feeding every day, the natural animal feed additive can be used for preventing and treating the infection from causative agents such as fungus, bacterium and virus causative agents to the animals, so that the immunity and the adversity resistance of various farmed animals are strengthened, the antibiotic used multi-component complex formula products are decreased, the inborn and acquired immunities of the animals can be strengthened, the response of the organism to various vaccines is remarkably improved so as to strengthen the comprehensive immunological competence of the organism for diseases, the death rate can be remarkably reduced at the paedomorphosis stage of the animals and the weight increment capability and other production capabilities of the animals can be improved at the adult growth state.
Owner:江苏铭仁生物科技发展有限公司

System and methods for assessing oral feeding skills during oral feeding

ActiveUS20180211558A1Optimize feeding performance and safety and competencyFeeding-bottlesDiagnostic recording/measuringMedicineSkill sets
The present invention relates to systems and methods for assessing and improving an infant's oral feeding skills. The system comprises a “smart” baby feeding device comprising an instrumented baby bottle with a removable, battery-powered monitoring module wirelessly connected to a remote device (e.g., smart phone, tablet, laptop, PC). The purpose of the remote device is to monitor (in real time) and measure the frequency and quality of feedings of new-born babies to help optimize feeding development by providing real-time feeding performance information back to the caregiver. The information collected is of assistance in minimizing feeding difficulties and correcting feeding deficiencies.
Owner:LAU CHANTAL

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders

Emerging evidence indicates that diminished activity of the vasoprotective axis of the renin-angiotensin system, constituting angiotensin converting enzyme2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to pulmonary hypertension (PH). However, clinical success for long-term delivery of ACE2 or Ang-(1-7) would require stability and ease of administration to increase patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect from acids and gastric enzymes; fusion to a transmucosal carrier facilitates effective systemic absorption. Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) attenuated monocrotaline (MCT)-induced increase in right ventricular systolic pressure, decreased pulmonary vessel wall thickness and improved right heart function in both prevention and reversal protocols. Furthermore, combination of ACE2 and Ang-(1-7) augmented the beneficial effects against cardio-pulmonary pathophysiology induced by MCT administration.Experiments have also been performed which indicate that this approach is also suitable for the treatment or inhibition of experimental uveitis and autoimmune uveoretinitis These studies provide proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary and ocular disease therapeutics.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA +1

Complex immunity strengthening agent for crabeater young fish

The invention relates to a compound immunopotentiator, particularly to a compound immunopotentiator for rachycentron canadum fries, and belongs to the field of feed additives for rachycentron canadum fries. The compound immunopotentiator for the rachycentron canadum fries is prepared from the following components (by wt%): Beta-glucan 20-25%, vitamin C-2-polyphosphonate 5-20%, vitamin E 8-15%, FeSO4*7H2O 5-20%, sodium selenite 0.2-0.5%, astragalus membranaceus 10-35%, radix bupleuri 5-20%, and glucose 5-30%. The compound immunopotentiator can be directly added into the feed of the rachycentron canadum fries for oral feeding or sprinkled over water where the rachycentron canadum fries live; and can remarkably improve the immunity and the disease resistance of the rachycentron canadum fries. The compound immunopotentiator has the advantages of no toxic and adverse residues, no drug resistance, environmental friendliness, no adverse effect on feed palatability, stable source of raw materials, and simple production process.
Owner:GUANGDONG EVERGREEN FEED INDAL

Feeding transition nipple mechanism and system

A feeding transition system for transitioning an infant subject to oral feeding includes at least one no-flow nipple and at least one flow nipple. The no-flow nipple has a fully enclosed tip portion such that no fluid can flow directly from the nipple cavity through the nipple wall. The flow nipple is formed of a no-flow nipple having an aperture formed in the tip portion for flowing fluid from the nipple cavity through the nipple wall. The system includes a bolus delivery nipple formed of a no-flow nipple including a bolus delivery conduit disposed in the nipple cavity and in fluid communication with a reservoir of fluid. The bolus delivery conduit includes a conduit outlet attached to the nipple wall to output a bolus of fluid from the tip portion of the bolus delivery nipple via the outlet. A method for transitioning an infant subject to oral feeding is provided.
Owner:NFANT LABS LLC

Predictive neurodevelopment therapy for oral feeding

The present disclosure relates to a therapeutic system and methods of using the therapeutic system. In particular, the present disclosure relates to a system for improving an oral feeding ability of a patient including an assessment device to contact a patient and collect data related to an oral feeding ability of the patient, a computing device containing a processor to execute an assessment and therapy application, and the assessment and therapy application to receive the data related to the oral feeding ability, predict one or more areas of neurological muscle activity that need further development, and develop a neurological therapy treatment for improving the one or more areas of neurological muscle activity that need further development.
Owner:INNARA HEALTH

Intact pea protein-based nutrient composition

The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is an intact pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and / or oral feeding.
Owner:KATE FARMS INC

Hydrolyzed Pea Protein-Based Nutrient Composition

The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and / or oral feeding.
Owner:KATE FARMS INC

Artificial domestication method of glyptosternum maculatum wild parent fish

The invention discloses an artificial domestication method of glyptosternum maculatum wild parent fish, and belongs to the technical field of aquaculture. The artificial domestication method comprisesthe steps of selecting wild glyptosternum maculatum parent fish; preparing a domestication pond; carrying out domestication of the parent fish; performing a paste bait feeding stage; feeding the parent fish with the paste bait by adopting an artificial oral feeding method on the day of fishing and transportation, and placing the parent fish in the domestication pond after transportation; performing a paste bait and live loach feeding stage; adopting live loaches to gradually replace paste baits for feeding, wherein the replacement method comprises the steps of carrying out feeding by the paste baits and the live loaches for 4-5 days according to the frequency ratio of 2 to 1 every day, and conducting feeding for three times every day; afterwards, carrying out feeding by the paste baits and the live loaches for 4-5 days according to the frequency ratio of 1 to 2 every day, and conducting feeding for three times every day; next, carrying out feeding with only the live loaches for 4-5 days, and conducting feeding for three times every day; executing a live loach feeding stage; after the feeding stage of the paste bait and the live loaches, continuously feeding by the live loaches; and conducting feeding twice a day. The method is used for artificial domestication of the glyptosternum maculatum wild parent fish.
Owner:HEILONGJIANG RIVER FISHERY RES INST CHINESE ACADEMY OF FISHERIES SCI

Natural animal feed additive

The invention discloses a natural animal feed additive which comprises the following components in mass percentage: 10-25% of allicin, 1-5% of beta-glucanase, 20-40% of diatomaceous earth, 5-15% of potassium sorbate, 25-50% of beer yeast cell wall and 0.5-1% of vitamin C. Mixing materials which are 0.01-5% of the dry weight of the natural animal feed additive is added in the natural animal feed additive; and by carrying out oral feeding every day, the natural animal feed additive can be used for preventing and treating the infection from causative agents such as fungus, bacterium and virus causative agents to the animals, so that the immunity and the adversity resistance of various farmed animals are strengthened, the antibiotic used multi-component complex formula products are decreased, the inborn and acquired immunities of the animals can be strengthened, the response of the organism to various vaccines is remarkably improved so as to strengthen the comprehensive immunological competence of the organism for diseases, the death rate can be remarkably reduced at the paedomorphosis stage of the animals and the weight increment capability and other production capabilities of the animals can be improved at the adult growth state.
Owner:江苏铭仁生物科技发展有限公司

Trans-cellulase gene recombinant lactobacilli and product and application of trans-cellulase gene recombinant lactobacilli

The invention relates to trans-cellulase gene recombinant lactobacilli and a product and application of the trans-cellulase gene recombinant lactobacilli. Protein coded by the trans-cellulase gene recombinant lactobacilli has an amino acid sequence shown in a sequence table SEQ ID NO.1. The trans-cellulase gene recombinant lactobacilli built by the invention can be used as an oral feed additive applied to the pig industry or poultry farming so as to compensate the defects that intestinal tracts of pigs, and birds cannot secrete cellulose without adding expensive cellulase preparation, not only facilitates metabolism of crude fiber in feed material, but also can promote growth of pigs and increase the economic benefits of cultivation. In addition, the host bacterium lactobacillus is lactobacillus casei, and has a probiotic function to an animal body. The invention provides an artificial cellulase probiotic genetic engineering lactobacillus, which has important application value in production of monogastric animals such as pigs, birds and the like.
Owner:HENAN UNIV OF SCI & TECH

Compound walnut and linseed oil fat emulsion intravenous injection and preparation method thereof

The invention provides a compound walnut and linseed oil fat emulsion intravenous injection and a preparation method thereof. The compound walnut and linseed oil fat emulsion intravenous injection comprises the raw materials of walnut oil, linseed oil, lecithin, glycerol, sterile pure water, antioxidants, stabilizing agents, pH regulating agents and the like. The preparation method comprises the following steps of: under the protection of nitrogen, heating, dissolving and mixing the walnut oil, the linseed oil and the lecithin into an oil phase; mixing the glycerol, the antioxidants, the stabilizing agents and the sterile pure water into a water phase, slowly adding the oil phase in the violently stirred water phase and then shearing in high speed to form a primary emulsion; and regulating the pH of the primary emulsion to 6.5-8.5 by using a few pH regulating agents, emulsifying by using a high-pressure viscolizer, filtering by using a microporous membrane, and then filling, sealing and sterilizing to obtain the compound walnut and linseed oil fat emulsion intravenous injection, wherein the total oil content of the intravenous injection is 1%-50%. The compound walnut and linseed oil fat emulsion intravenous injection and the preparation method thereof are used in the fields of medical treatment and health, and the compound walnut and linseed oil fat emulsion intravenous injection can be administrated through abenteric intravenous injection or intestinal tube feeding or oral feeding and can be used as a nutritional and therapeutic medicament.
Owner:王京南

Self-assembling protein for forming pharmaceutical compound

InactiveCN106831952AExtended concentration durationGuaranteed Oral StabilityPowder deliveryPeptide/protein ingredientsMedicineOral feeding
The invention relates to a self-assembling protein for forming a pharmaceutical compound, belonging to the technical field of biology. The self-assembling protein has an amino acid residue sequence shown in SEQ ID NO 1 as well as a general formula as follows: QQCTTGQLQCCESTSTANDPATSELLGLIGVVISDVDA LVGLTCSPISVIGVGSGSACTANPVCCDSSPIGGLVSIGCVPVNV SEQ ID NO 1. A supporting agent based on the self-assembling protein and a pharmaceutical composition prepared from the supporting agent can be used as oral feeding medication carriers of GLP-1 for treating type 2 diabetes mellitus.
Owner:天津世传生物科技有限公司

Intact Pea Protein-Based Nutrient Composition

The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is an intact pea protein based nutrient composition for use in both enteral and oral feeding, and provides a nonallergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and / or oral feeding.
Owner:KATE FARMS INC

Magnet for treatment under endoscope

ActiveCN108309384AIschemic necrosisShort eating timeSurgeryMagnetic polesEngineering
The invention relates to a magnet for treatment under an endoscope. The magnet comprises one or more magnet bodies, magnetic poles of the magnet bodies are arranged at the upper and lower ends of themagnet bodies, and one or more connection ropes are arranged on the magnet bodies; one end of each connection rope is connected with the corresponding magnet body, and the other end of each connectionrope is provided with a rope ring; the end faces of the upper and lower ends of each magnet body are planes parallel to each other, the cross sections of the magnet bodies are circular, the diametersof the cross sections of the magnet bodies are larger than the heights of the magnet bodies, and the end faces of the upper and lower ends of the magnet bodies are rough faces. The magnet is simple in structure and convenient to operate and can be placed at the two sides of a target object, the two magnet bodies attract each other and compress the target object, avascular necrosis of mucous membranes on the junction parts is achieved, then channels are formed at the two ends which the magnet fits, and the treatment effect is achieved; or a condition is created for next treatment under the endoscope. Less complications are caused, the hospitalization period is short, and the recovery time for oral feeding is short.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Orthotropic and Orthognathic Oral Device and Method

PendingUS20210308017A1Avoid hematomaPrecise alignmentTeatsOral feedingPacifier
A hygienic oral feed-bottle nipple includes an opening skirt to expand and rotate in the buccal vestibule. As the child completes the suckling cycle, the mouth portion is distorted, the skirt extended to provide cleaning, stimulation, and a bumper to deny extensive pronation. The flanges and skirt may be covered with a textured surface, or bristles, that provide mechanical brushing of oral surfaces. Hard pads set along a superior surface of the nipple are compressed against the maxilla palate and provide upwards and / or lateral force to encourage lateral expansion of the palate. The nipple may be bifurcated into left and right opposing lobes which can split laterally to enhance lateral force on maxilla.
Owner:SAMANDARI NAFYS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products